The hires, promotions and boardroom changes reshaping leadership across pharma manufacturing, biotech and the CDMO landscape.

Marcus Adeyemi, previously VP of Sterile Operations at Sterigenix, has been appointed Chief Executive Officer of Aventa CDMO effective July 2026.

Dr. Ingrid Halvorsen, chair of Aventa CDMO and former CSO of Nordic BioPharma, has been named CEO of Sterigenix following the departure of founder-CEO Peter Bergman.
Meridian Pharma has appointed Dr. Lena Brandt as CSO, effective September 2026. Brandt joins from Bayer, where she led rare-disease discovery.
PureLine Labs has appointed Dr. Sanjay Kulkarni as Head of Manufacturing Sciences. Kulkarni was previously Director of Continuous Manufacturing at Cipla.